ONCOLYTICS BIOTECH (U.S.), INC.
Share on:
| Name: | ONCOLYTICS BIOTECH (U.S.), INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 03 Oct 2016 (9 years ago) |
| Entity Number: | 5017703 |
| ZIP code: | 12260 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 99 WASHINGTON AVE., STE. 700, ALBANY, NY, United States, 12260 |
| Principal Address: | 322 - 11th Avenue S.W., Suite 804, Calgary, Alberta T2R 0C5, Calgary, Canada |
| Name | Role | Address |
|---|---|---|
| REGISTERED AGENT SOLUTIONS, INC. | DOS Process Agent | 99 WASHINGTON AVE., STE. 700, ALBANY, NY, United States, 12260 |
| Name | Role | Address |
|---|---|---|
| GILLES L. GOSSELIN | Chief Executive Officer | 322 - 11TH AVENUE S.W., SUITE 804, CALGARY, ALBERTA T2R 0C5, CALGARY, Canada |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-10-08 | 2024-10-08 | Address | 322 - 11TH AVENUE S.W., SUITE 804, CALGARY, ALBERTA T2R 0C5, CALGARY, CAN (Type of address: Chief Executive Officer) |
| 2024-10-08 | 2024-10-08 | Address | 322 - 11TH AVENUE SW, SUITE 804, CALGARY, ALBERTA, CAN (Type of address: Chief Executive Officer) |
| 2024-10-08 | 2024-10-08 | Address | 210, 1167 KENSINGTON CRESCENT, CALGARY, CAN (Type of address: Chief Executive Officer) |
| 2024-08-27 | 2024-10-08 | Address | 210, 1167 KENSINGTON CRESCENT, CALGARY, CAN (Type of address: Chief Executive Officer) |
| 2024-08-27 | 2024-08-27 | Address | 322 - 11TH AVENUE SW, SUITE 804, CALGARY, ALBERTA, CAN (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 241008002448 | 2024-10-08 | BIENNIAL STATEMENT | 2024-10-08 |
| 240827002248 | 2024-08-22 | CERTIFICATE OF CHANGE BY AGENT | 2024-08-22 |
| 221006003733 | 2022-10-06 | BIENNIAL STATEMENT | 2022-10-01 |
| 201006060638 | 2020-10-06 | BIENNIAL STATEMENT | 2020-10-01 |
| 181010006135 | 2018-10-10 | BIENNIAL STATEMENT | 2018-10-01 |
This company hasn't received any reviews.
Date of last update: 24 Mar 2025
Sources: New York Secretary of State